Two amino acid substitutions in the type 3 poliovirus capsid contribute to the establishment of persistent infection in HEp-2c cells by modifying virus-receptor interactions

Virology

Volumn 241, Issue 1, 1998, Pages 14-29

  Duncan, Gillian ^a   Pelletier, Isabelle ^a   Colbère Garapin, Florence ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; HEP 2 CELL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PERSISTENT VIRUS INFECTION; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS MUTATION;

ANIMALIA; DNA VIRUSES; MIRIDAE; POLIOVIRUS; RNA VIRUSES;

EID: 0032005670     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8955     Document Type: Article

References (45)

1. Blondel B., Akacem O., Crainic R., Couillin P., Horodniceanu F. Detection by monoclonal antibodies of an antigenic determinant critical for poliovirus neutralization present on VP1 and on heat inactivated virions. Virology. 126:1983;707-710.
2. Borzakian S., Couderc T., Barbier Y., Attal G., Pelletier I., Colbère-Garapin F. Persistent poliovirus infection: establishment and maintenance involve distinct mechanisms. Virology. 186:1992;398-408.
3. Borzakian S., Pelletier I., Calvez V., Colbère-Garapin F. Precise missense and silent point mutations are fixed in the genomes of poliovirus mutants from persistently infected cells. J. Virol. 67:1993;2914-2917.
4. Calvez V., Pelletier I., Borzakian S., Colbère-Garapin F. Identification of a region of the poliovirus genome involved in persistent infection of HEp-2 cells. J. Virol. 67:1993;4432-4435.
5. Calvez V., Pelletier I., Couderc T., Pavio-Guédo N., Blondel B., Colbère-Garapin F. Cell clones cured of persistent poliovirus infection display selective permissivity to the wild-type poliovirus strain Mahoney and partial resistance to the attenuated Sabin 1 strain and Mahoney mutants. Virology. 212:1995;309-322.
6. Christodoulou C., Pelletier I., Colbère-Garapin F. Genetic stability of poliovirus insertion mutants with a foreign oligopeptide on the capsid surface. Res. Virol. 140:1989;501-509.
7. Colbère-Garapin F., Christodoulou C., Crainic R., Pelletier I. Persistent poliovirus infection of human neuroblastoma cells. Proc. Natl. Acad. Sci. USA. 86:1989;7590-7594.
8. Colbère-Garapin F., Horodniceanu F., Kourilsky P., Garapin A. C. A new dominant hybrid selective marker for higher eukaryotic cells. J. Mol. Biol. 150:1981;1-14.
9. Colston E., Racaniello V. R. Soluble receptor-resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor. EMBO J. 13:1994;5855-5862.
10. Couderc T., Delpeyroux F., Leblay H., Blondel B. Mouse adaptation determinants of poliovirus type 1 enhance viral uncoating. J. Virol. 70:1996;305-312.
11. Curry S., Chow M., Hogle J. M. The poliovirus 135S particle is infectious. J. Virol. 70:1996;7125-7131.
12. de la Torre J. C., Davila M., Sobrino F., Ortin J., Domingo E. Establishment of cell lines persistently infected with foot-and-mouth disease virus. Virology. 145:1985;24-35.
13. De Sena J., Mandel B. Studies on thein vitro. Virology. 78:1977;554-561.
14. Domingo E., Martinez-Salas E., Sobrino F., de la Torre J. C., Portela A., Ortin J., Lopez-Galindez C., Perez-Brena P., Villanueva N., Najera R., VandePol S., Steinhauer D., DePolo N., Holland J. The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: Biological relevance - A review. Gene. 40:1985;1-8.
15. Dove A. W., Racaniello V. R. Cold-adapted poliovirus mutants bypass a postentry replication block. J. Virol. 71:1997;4728-4735.
16. Everaert L., Vrijsen R., Boeyé A. Eclipse products of poliovirus after cold-synchronized infection of HeLa cells. Virology. 171:1989;76-82.
17. Fenwick M. L., Cooper P. D. Early interactions between poliovirus and ERK cells. Some observations on the nature and significance of the rejected particles. Virology. 18:1962;212-223.
18. Filman D. J., Syed R., Chow M., Macadam A. J., Minor P. D., Hogle J. M. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J. 8:1989;1567-1579.
19. Flore O., Fricks C. E., Filman D. J., Hogle J. M. Conformational changes in poliovirus assembly and cell entry. Seminars in Virology. 1990;Saunders, London. p. 429-438.
20. Fricks C. E., Hogle J. M. Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding. J. Virol. 64:1990;1934-1945.
21. Gercel C., Mahan K. B., Hamparian V. V. Preliminary characterization of a persistent infection of HeLa cells with human rhinovirus type 2. J. Gen. Virol. 66:1985;131-139.
22. Gomez Yafal A., Kaplan G., Racaniello V. R., Hogle J. M. Characterization of poliovirus conformational alteration mediated by soluble cell receptors. Virology. 197:1993;501-505.
23. Graham F. L., Van der Eb A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52:1973;456-467.
24. Gratsch T. E., Righthand V. F. Construction of a recombinant cDNA of echovirus 6 that established a persistentin vitro. Virology. 201:1994;341-348.
25. Harber J., Bernhardt G., Lu H. H., Sgro J. Y., Wimmer E. Canyon rim residues, including antigenic determinants, modulate serotype-specific binding of polioviruses to mutants of the poliovirus receptor. Virology. 214:1995;559-570.
26. Jarousse N., Martinat C., Syan S., Brahic M., McAllister A. Role of VP2 amino acid 141 in tropism of Theiler's virus within the central nervous system. J. Virol. 70:1996;8213-8217.
27. Joklik W. K., Darnell J. E. The adsorption and early fate of purified poliovirus in HeLa cells. Virology. 13:1961;439-447.
28. Kaplan G., Freistadt M. S., Racaniello V. R. Neutralization of poliovirus by cell receptors expressed in insect cells. J. Virol. 64:1990;4697-4702.
29. Koike S., Horie H., Ise I., Okitsu A., Yoshida M., Iizuka N., Takeuchi K., Takegami T., Nomoto A. The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J. 9:1990;3217-3224.
30. Kronenberger P., Vrijsen R., Boeyé A. Cellular proteolysis of poliovirus eclipse particles is abortive. J. Gen. Virol. 75:1994;473-580.
31. Lonberg-Holm K. L., Gosser L. B., Kauer J. C. Early alteration of poliovirus in infected cells and its specific inhibition. J. Gen. Virol. 27:1975;329-342.
32. Matteucci D., Paglianti M., Giangregorio A. M., Capobianchi M. R., Dianzani F., Bendinelli M. Group B coxsackieviruses readily establish persistent infections in human lymphoid cell lines. J. Virol. 56:1985;651-654.
33. Messing J., Gronenborn B., Muller-Hill B., Hofschneider P. H. Filamentous coliphage M13 as a cloning vehicle: Insertion of a Hind II fragment of the lac regulatory region in M13 replicative formin vitro. Proc. Natl. Acad. Sci. USA. 74:1977;3642-3646.
34. Minor P. D., Ferguson M., Evans D. M. A., Almond J. W., Icenogle J. P. Antigenic structure of polioviruses of serotypes 1, 2 and 3. J. Gen. Virol. 67:1986;1283-1291.
35. Morrison M. E., He Y. J., Wien M. W., Hogle J. M., Racaniello V. R. Homolog-scanning mutagenesis reveals poliovirus receptor residues important for virus binding and replication. J. Virol. 68:1994;2578-2588.
36. Olson N. H., Kolatkar P. R., Oliveira M. A., Cheng R. H., Greve J. M., McClelland A., Baker T. S., Rossmann M. G. Structure of a human rhinovirus complexed with its receptor molecule. Proc. Natl. Acad. Sci. USA. 90:1993;507-511.
37. Omata T., Kohara M., Sakai Y., Kameda A., Imura N., Nomoto A. Cloned infectious complementary DNA of the poliovirus Sabin 1. Gene. 32:1984;1-10.
38. Pelletier I., Couderc T., Borzakian S., Wyckoff E., Crainic R., Ehrenfeld E., Colbère-Garapin F. Characterization of persistent poliovirus mutants selected in human neuroblastoma cells. Virology. 180:1991;729-737.
39. Racaniello V. R., Baltimore D. Cloned poliovirus complementary DNA is infectious in mammalian cells. Science. 214:1981;916-919.
40. Ren R., Moss E. G., Racaniello V. R. Identification of two determinants that attenuate vaccine-related type 2 poliovirus. J. Virol. 65:1991;1377-1382.
41. Salvato M., Borrow P., Shimomaye E., Oldstone M. B. A. Molecular basis of viral persistence: A single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence. J. Virol. 65:1991;1863-1869.
42. 1. Proc. Natl. Acad. Sci. USA. 81:1984;1539-1543.
43. Tosteson M. T., Chow M. Characterization of the ion channels formed by poliovirus in planar lipid membranes. J. Virol. 71:1997;507-511.
44. Vallbracht A., Hofmann L., Wurster K. G., Flehmig B. Persistent infection of human fibroblasts by hepatitis A virus. J. Gen. Virol. 65:1984;609-615.
45. van der Werf S., Bradley J., Wimmer E., Studier F. W., Dunn J. J. Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase. Proc. Natl. Acad. Sci. USA. 83:1986;2330-2334.